222 Genetic reprogramming of merkel cell carcinoma and melanoma leads to increased MHC-I expression and antitumor immune activation in vitro and in vivo

• Jordan Green,
• Kathryn Luly,
• Stephany Tzeng,
• Joel Sunshine

Affiliations

Jordan Green

Radiology, King`s College Hospital NHS Foundation Trust, London, UK

Kathryn Luly

Johns Hopkins University, Baltimore, MD, USA

Stephany Tzeng

Johns Hopkins University, Baltimore, MD, USA

Joel Sunshine

Johns Hopkins University, Baltimore, MD, USA